Here, we created recombinant proteins of the extracellular domain of TM and found that TMD123-Fc and TMD12-Fc inhibited the β1 integrin-dependent binding of human breast cancer-derived cell lines to fibronectin (Figure 5, Figure 6 and Figure 7). The gene discussed is FN1; the disease is breast carcinoma.